Product Code: GVR-4-68040-163-6
Suture Anchor Devices Market Growth & Trends:
The global suture anchor devices market size is expected to reach USD 1,003.4 million by 2030, expanding at a CAGR of 3.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of orthopedic conditions such as bone fractures, joint dislocations, and ligament tears often require surgical interventions. Suture anchors play a crucial role in stabilizing and securing soft tissues during these procedures. The increasing demand for minimally invasive surgeries (MIS) is another major factor propelling market growth. MIS techniques offer several advantages over traditional open surgeries, such as reduced incision size, minimized tissue trauma, and faster recovery times.
Industry growth can also be attributed to continuous technological advancements, increasing environmental consciousness, and a steadily rising demand for streamlined surgical procedures. For instance, the development of advanced biomaterials is fueling market expansion. These materials possess enhanced biocompatibility, mechanical strength, and resorption properties, making them suited for suture anchors. Bioabsorbable suture anchors, which gradually dissolve over time, are gaining traction due to their ability to eliminate the need for a second surgery for anchor removal.
Several key players are undertaking various initiatives such as acquisitions, product launches, and partnerships to strengthen their market position. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. Thus, companies can drive innovation, stay flexible, and quickly respond to the ever-changing needs of suture anchor devices. For instance, in December 2022, Stryker introduced the Citrefix suture anchor system, incorporating Citregen, an acclaimed bioresorbable material engineered to rival natural bone chemistry and structure. This innovative system aims to boost bone regeneration and aid the body's inherent healing mechanisms.
Suture Anchor Devices Market Report Highlights:
- In 2024, non-absorbable products dominated the market for suture anchor devices, owing to a rising prevalence of major orthopedic conditions, such as bone fractures, joint dislocations, and ligament tears, which usually require surgical intervention
- Metallic suture anchors segment held a larger share in terms of material type in 2024, owing to this material's superior mechanical strength, durability, and biocompatibility, making it ideal for use in orthopedic surgeries
- In 2024, the knotless segment dominated with regards to tying type, as it simplifies surgical procedures by eliminating the knot-tying process, thereby saving time and reducing complexity
- The hospitals segment dominated in terms of end-use in 2024, owing to the rising prevalence of orthopedic conditions globally
- North America accounted for the largest market share in 2024 due to this region's well-developed healthcare infrastructure, and high adoption rate of suture anchor products
- Market players adopt several strategic initiatives to improve their product's reach and increase its availability in diverse geographic regions
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Material
- 1.2.3. Tying Type
- 1.2.4. End Use
- 1.2.5. Regional Scope
- 1.2.6. Estimates and Forecasts Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.5. Information or Data Analysis
- 1.6. Data Analysis Models
- 1.7. Market Formulation & Validation
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2.Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Material Outlook
- 2.2.3. Tying Type Outlook
- 2.2.4. End Use Outlook
- 2.2.5. Regional Outlook
- 2.3. Competitive Insights
Chapter 3.Suture Anchor Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Suture Anchor Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrant
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Technological Landscape
- 3.3.2.3. Economic Landscape
Chapter 4. Suture Anchor Devices Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Suture Anchor Devices Market: Product Movement Analysis
- 4.3. Global Suture Anchor Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Absorbable
- 4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.5. Non-Absorbable
- 4.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter5.Suture Anchor Devices Market: Material Estimates & Trend Analysis
- 5.1. Material Segment Dashboard
- 5.2. Suture Anchor Devices Market: Material Movement Analysis
- 5.3. Global Suture Anchor Devices Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
- 5.4. Metallic Suture Anchor
- 5.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.5. Bio-Absorbable Suture Anchor
- 5.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 6.Suture Anchor Devices Market: Tying Type Estimates & Trend Analysis
- 6.1. Tying Type Segment Dashboard
- 6.2. Suture Anchor Devices Market: Tying Type Movement Analysis
- 6.3. Global Suture Anchor Devices Market Size & Trend Analysis, by Tying Type, 2018 to 2030 (USD Million)
- 6.4. Knotted Suture Anchors
- 6.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 6.5. Knotless Suture Anchors
- 6.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 7. Suture Anchor Devices Market: End Use Estimates & Trend Analysis
- 7.1. End Use Segment Dashboard
- 7.2. Suture Anchor Devices Market: End Use Movement Analysis
- 7.3. Global Suture Anchor Devices Market Size & Trend Analysis, By End Use, 2018 To 2030 (USD Million)
- 7.4. Hospitals
- 7.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.5. Ambulatory Surgical Centers
- 7.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6. Clinics
- 7.6.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 8. Suture Anchor Devices Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Dashboard
- 8.2. Regional Market Share Analysis, 2024 & 2030
- 8.3. Continuous Bioprocessing Market by Region: Key Takeaways
- 8.4. North America
- 8.4.1. U.S.
- 8.4.1.1. Key Country Dynamics
- 8.4.1.2. Regulatory Framework/ Reimbursement Structure
- 8.4.1.3. Competitive Scenario
- 8.4.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.4.2. Canada
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Regulatory Framework/ Reimbursement Structure
- 8.4.2.3. Competitive Scenario
- 8.4.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.4.3. Mexico
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Regulatory Framework/ Reimbursement Structure
- 8.4.3.3. Competitive Scenario
- 8.4.3.4. Mexico Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5. Europe
- 8.5.1. Germany
- 8.5.1.1. Key Country Dynamics
- 8.5.1.2. Regulatory Framework
- 8.5.1.3. Competitive Scenario
- 8.5.1.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.2. UK
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Regulatory Framework
- 8.5.2.3. Competitive Scenario
- 8.5.2.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.3. France
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Regulatory Framework
- 8.5.3.3. Competitive Scenario
- 8.5.3.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.4. Italy
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Regulatory Framework
- 8.5.4.3. Competitive Scenario
- 8.5.4.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.5. Spain
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Regulatory Framework
- 8.5.5.3. Competitive Scenario
- 8.5.5.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.6. Denmark
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Regulatory Framework
- 8.5.6.3. Competitive Scenario
- 8.5.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.7. Sweden
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Regulatory Framework
- 8.5.7.3. Competitive Scenario
- 8.5.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.5.8. Norway
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Regulatory Framework
- 8.5.8.3. Competitive Scenario
- 8.5.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.1.1. Key Country Dynamics
- 8.6.1.2. Regulatory Framework
- 8.6.1.3. Competitive Scenario
- 8.6.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.6.2. China
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Regulatory Framework
- 8.6.2.3. Competitive Scenario
- 8.6.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.6.3. India
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Regulatory Framework
- 8.6.3.3. Competitive Scenario
- 8.6.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.6.4. South Korea
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Regulatory Framework
- 8.6.4.3. Competitive Scenario
- 8.6.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.6.5. Australia
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Regulatory Framework
- 8.6.5.3. Competitive Scenario
- 8.6.5.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.6.6. Thailand
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Regulatory Framework
- 8.6.6.3. Competitive Scenario
- 8.6.6.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Brazil
- 8.7.1.1. Key Country Dynamics
- 8.7.1.2. Regulatory Framework
- 8.7.1.3. Competitive Scenario
- 8.7.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.7.2. Argentina
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Regulatory Framework
- 8.7.2.3. Competitive Scenario
- 8.7.2.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.8. MEA
- 8.8.1. South Africa
- 8.8.1.1. Key Country Dynamics
- 8.8.1.2. Regulatory Framework
- 8.8.1.3. Competitive Scenario
- 8.8.1.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.8.2. Saudi Arabia
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Regulatory Framework
- 8.8.2.3. Competitive Scenario
- 8.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.8.3. UAE
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Regulatory Framework
- 8.8.3.3. Competitive Scenario
- 8.8.3.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 8.8.4. Kuwait
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Regulatory Framework
- 8.8.4.3. Competitive Scenario
- 8.8.4.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 9.Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. Key Company Heat Map Analysis, 2024
- 9.4. Company Profiles
- 9.4.1. Smith & Nephew, plc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Zimmer Biomet Holdings, Inc.
- 9.4.2.1. Company Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. CONMED Corporation
- 9.4.3.1. Company Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Arthrex, Inc.
- 9.4.4.1. Company Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Johnson & Johnson Services, Inc. (Depuy Synthes, Inc.)
- 9.4.5.1. Company Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Stryker (Wright Medical Group, Inc.)
- 9.4.6.1. Company Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Parcus Medical, LLC (Medacta International)
- 9.4.7.1. Company Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Orthomed, Inc.
- 9.4.8.1. Company Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Enovis Corporation
- 9.4.9.1. Company Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Medtronic
- 9.4.11. Company Overview
- 9.4.12. Financial Performance
- 9.4.13. Product Benchmarking
- 9.4.14. Strategic Initiatives